Last reviewed · How we verify
NCT02611011
Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Survey
trial testing Congo Red Test (GV-005) in Preeclampsia in 198 participants. Completed in 30 December 2018.
30 June 2018
Quick facts
| Lead sponsor | Gynuity Health Projects |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 198 |
| Start date | 1 March 2018 |
| Primary completion | 30 June 2018 |
| Estimated completion | 30 December 2018 |
| Sites | 1 location across Mexico |
Drugs / interventions tested
- Congo Red Test (GV-005)
Conditions studied
- Preeclampsia — all drugs for Preeclampsia →
Sponsor
Gynuity Health Projects — full company profile →
Who can join
Adults 10 to 50, female only, with Preeclampsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if women can understand the instructions, carry out the test, and interpret the test results. Women will be recruited to complete a test instruction and comprehension assessment and a usability assessment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02611011
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preeclampsia
Currently open trials in the same condition.
- NCT06953115 — Vagal Stimulation Therapy and Preeclampsia · NA · recruiting
- NCT06333652 — Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders · Phase 2 · recruiting
- NCT07282171 — A Study to Investigate the Safety, Pharmacodynamic and Pharmacokinetic Characteristics of CBP-4888 in Hospitalized Parti · Phase 1 · recruiting
- NCT07345845 — MR and Inflammation After Preeclampsia · EARLY_PHASE1 · active not recruiting
- NCT07041281 — Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories · Phase 2 · recruiting
Other Gynuity Health Projects trials
Trials by the same sponsor.
- NCT06492889 — Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens · Phase 2, PHASE3 · not yet recruiting
- NCT05781061 — MA-ASAP at Independent Abortion Clinics: A Demonstration Project · NA · completed
- NCT05119439 — Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks · Phase 4 · terminated
- NCT05459142 — Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan. · completed
- NCT05278780 — Medication Abortion With Autonomous Self-Assessment Project · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02611011 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gynuity Health Projects
- Last refreshed: 3 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02611011.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing